Variant report
Variant | nsv224 |
---|---|
Chromosome Location | chr2:126439664-126461757 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:126441721..126443799-chr2:126451980..126453632,2 | K562 | blood: | |
2 | chr2:126441149..126442866-chr2:126450432..126451944,2 | K562 | blood: | |
3 | chr2:126441149..126442866-chr2:126450432..126451944,2 | K562 | blood: | |
4 | chr2:126441721..126443799-chr2:126451980..126453632,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CNTNAP5-2 | chr2:126456152-126456276 | NONHSAT074117 |
2 | lnc-CNTNAP5-2 | chr2:126456152-126456276 | FPKM1_group_17139_transcript_1 |
3 | lnc-CNTNAP5-2 | chr2:126457983-126458113 | FPKM1_group_17139_transcript_1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76423360 | chr2:126439676-126439677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200405886 | chr2:126439677-126439678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536889280 | chr2:126439678-126439679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201250407 | chr2:126439679-126439680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536215041 | chr2:126439712-126439713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555640290 | chr2:126439750-126439751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536286029 | chr2:126439772-126439773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375504259 | chr2:126439804-126439805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369887677 | chr2:126439868-126439869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374028909 | chr2:126439877-126439878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs199617230 | chr2:126439885-126439886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376172352 | chr2:126439895-126439896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577391808 | chr2:126439902-126439903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142396906 | chr2:126439951-126439952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181854827 | chr2:126439973-126439974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11428634 | chr2:126439984-126439985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11404244 | chr2:126439985-126439986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs397769273 | chr2:126439986-126439987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111925087 | chr2:126439987-126439988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113811116 | chr2:126439988-126439989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111234304 | chr2:126439989-126439990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573311068 | chr2:126440027-126440028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185496237 | chr2:126440035-126440036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144731507 | chr2:126440095-126440096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528823188 | chr2:126440104-126440105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189805377 | chr2:126440123-126440124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs180715334 | chr2:126440127-126440128 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545179642 | chr2:126440135-126440136 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2052815 | chr2:126440151-126440152 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs186556982 | chr2:126440185-126440186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561321486 | chr2:126440223-126440224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376000061 | chr2:126440233-126440234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546720483 | chr2:126440247-126440248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564797405 | chr2:126440271-126440272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566840783 | chr2:126440273-126440274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534636365 | chr2:126440293-126440294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551232034 | chr2:126440294-126440295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571123082 | chr2:126440300-126440301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs151183331 | chr2:126440378-126440379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556639483 | chr2:126440390-126440391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370250045 | chr2:126440407-126440408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573701598 | chr2:126440422-126440423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536336630 | chr2:126440455-126440456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552723000 | chr2:126440472-126440473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs2052814 | chr2:126440477-126440478 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs149108026 | chr2:126440479-126440480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183726974 | chr2:126440483-126440484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs5834121 | chr2:126440516-126440517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs3980633 | chr2:126440537-126440538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78601280 | chr2:126440538-126440539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:126438600-126440600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:126439400-126440800 | Enhancers | Rectal Mucosa Donor 29 | rectum |
3 | chr2:126439400-126441200 | Enhancers | Adipose Nuclei | Adipose |
4 | chr2:126440000-126440200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr2:126440600-126441400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr2:126441400-126443000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr2:126441600-126443200 | Enhancers | GM12878-XiMat | blood |
8 | chr2:126442800-126443200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr2:126443000-126443200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr2:126451800-126453200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr2:126453800-126454200 | Enhancers | Brain Substantia Nigra | brain |
12 | chr2:126453800-126454600 | Enhancers | Brain Hippocampus Middle | brain |
13 | chr2:126454000-126455200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
14 | chr2:126454000-126455200 | Enhancers | Hela-S3 | cervix |
15 | chr2:126454200-126455200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |